BioInformant

Your Global Leader in Stem Cell Market Research

Home » market news » Page 8

BioInformant to Sponsor 2015 World Stem Cell Summit to Support Stem Cell Advancement

By Leave a Comment

PRESS RELEASE; Washington, DC; November 17, 1015 — BioInformant, the only market research firm to serve the stem cell sector since it emerged, announces its sponsorship of the upcoming World Stem Cell Summit 2015 produced by the Genetics Policy Institute (GPI). The conference will be held in Atlanta, Georgia, over December 10-12, 2015.

The event is the world’s largest interdisciplinary meeting to bring together stakeholders from across the stem cell and regenerative medicine spectrum. Described as GPI as bringing together “prominent industry leaders, scientists, clinicians, venture capitalists and angel investors, philanthropists, policymakers, and advocates,” the event will provide seven different course tracks featuring more than 200 speakers. [Read more…]

Consolidation Continues within the Cord Blood Market – AlphaCord Acquires LifeSource Cryobank

By Leave a Comment

Today, AlphaCord released the major news that it is acquiring LifeSource Cryobank. This merger continues the trend of consolidation within the global cord blood banking market. It also continues AlphaCord’s trend of consolidation, as this was its fifth acquisition of smaller cord blood banks.

Earlier this year, on June 29, 2015, the largest cord blood bank in the United States and the world, Cord Blood Registry® (CBR®) announced that it had entered into a definitive agreement to be acquired by AMAG Pharmaceuticals, a company based out of Based in Waltham, Massachusetts. The value of the deal was set at $700 million, which established value of over 5.55 times revenue and over 15.55 times EBITDA. [Read more…]

3 Bullet Thursday – Astellas Acquires Ocata, CDI Partners with Roche, and iPSC Trial for Parkinson’s Delayed

By Leave a Comment

Stay alert to the latest and greatest on stem cells.  Enjoy this week’s “3 Bullet Thursday,” a weekly post that we do to update you on interesting and important events within the world of stem cells. 

1. In major news this week, Astellas Pharma announced it is acquiring Ocata Therapeutics for $379M. Astellas, a major drug company in Japan, will pay $8.50 a share, a 79% premium over the stock price last Friday. Ocata, which changed its name from Advanced Cell Technology last November, specializes in using pluripotent stem cells, such as embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), to treat diseases of the eye. [Read more…]

3 Bullet Thursday – 3D Printing Skulls, Stem Cell ‘Legos’, and Degree Revocation

By Leave a Comment

Stay alert to the latest and greatest on stem cells.  Enjoy this week’s “3 Bullet Thursday,” a weekly post that we do to update you on interesting and important events within the world of stem cells. 

1. Wow, Australian scientists are attempting to regrow human skulls with stem cells and 3D printing technology. Specifically, scientists will print a bio-ceramic scaffold less than 100 microns (0.1mm) thick and then inject millions of stem cells, making it the first time stem cells have been used on a 3D printed scaffold to regrow bone.

2. In other exciting news, scientists have discovered how to 3D print “building blocks” of embryonic stem cells. These cell blocks, capable of differentiating into any cell of the body, could potentially be used as the ‘Lego bricks’ to build tissues or even micro-organs.

3. In other controversial news, Dr. Haruko Obokata, the young Japanese scientist responsible for the STAP stem cell scandal, is being stripped of her doctoral degree. The president of Waseda University announced the degree revocation on Monday.

Enjoy your Thursday!

Want to get this fun weekly update?  Join below and we’ll keep you in the loop, starting next week.

* Need more in-depth analysis for the stem cell or cord blood industry? View our global strategic reports here.

 

3 Bullet Thursday – Stem Cells for Bioprinting, Fertility, & Replacement Organs (Oct 22, 2015)

By Leave a Comment

Stay alert to the latest and greatest on stem cells.  Enjoy this week’s “3 Bullet Thursday,” a weekly post that we do to update you on interesting and important events within the world of stem cells.

1. RoosterBio has released the world’s first ever ready-to-print (RTP) stem cell product, “thaw and use” human mesenchymal stem cells (hMSCs). This advance will make standardized cells accessible for rapid 3D bioprinting and tissue engineering. Totally incredible.

2. Scientists from Egypt’s Mansoura Medical School have successfully reversed infertility from cancer by directly injecting stem cells into the ovaries.

3. Will we eventually grow replacements organs using our own stem cells? It’s possible, as two research teams released news of growing kidney structures from stem cells within the past month.

First, an American team lead by Dr. Ryuji Morizane published findings in Nature Biotechnology that they had converted induced pluripotent stem cells (iPSCs) into kidney structures that resemble those from a normal human kidney.

Second, a team of Australian researchers lead by Dr. Minoru Takasato successfully grew nephron organoids from iPSCs, releasing their results in Nature.

It’s been quite a week. Happy Thursday!

Want to get this fun weekly update?  Join below and we’ll keep you in the loop, starting next week!

BioInformant's World-Class Clients